In Vivo Structure–Activity Relationship Studies Support Allosteric Targeting of a Dual Specificity Phosphatase
Citations Over TimeTop 14% of 2014 papers
Abstract
Dual specificity phosphatase 6 (DUSP6) functions as a feedback attenuator of fibroblast growth factor signaling during development. In vitro high throughput chemical screening attempts to discover DUSP6 inhibitors have yielded limited success. However, in vivo whole-organism screens of zebrafish identified compound 1 (BCI) as an allosteric inhibitor of DUSP6. Here we designed and synthesized a panel of analogues to define the structure-activity relationship (SAR) of DUSP6 inhibition. In vivo high-content analysis in transgenic zebrafish, coupled with cell-based chemical complementation assays, identified structural features of the pharmacophore of 1 that were essential for biological activity. In vitro assays of DUSP hyperactivation corroborated the results from in vivo and cellular SAR. The results reinforce the notion that DUSPs are druggable through allosteric mechanisms and illustrate the utility of zebrafish as a model organism for in vivo SAR analyses.
Related Papers
- → Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells(2010)179 cited
- → P2X7 Nucleotide and EGF Receptors Exert Dual Modulation of the Dual-Specificity Phosphatase 6 (MKP-3) in Granule Neurons and Astrocytes, Contributing to Negative Feedback on ERK Signaling(2018)24 cited
- → Infrequent methylation of the DUSP6 phosphatase in endometrial cancer(2010)13 cited
- → Dual Specificity Phosphatase 6 (DUSP6) regulates T cell responses and experimental colitis in mice(2011)
- → Inhibition of dual specificity phosphatase 6 (DUSP6) sensitizes ovarian cancer cells to chemotherapeutic agents(2019)